If validated, the risk score could help guide decisions around surveillance and risk-reduction treatments for patients with in situ breast disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback